Citations

Showing 10 of 108119 citations.

The Perception of the Visual World . James J. Gibson; Leonard Carmichael, Ed. Boston: Houghton Mifflin, 1950. 235 pp. $4.00.
Ogle, Kenneth N.

Mayo Clinic

Science | October 22, 2021 | Volume: 113 | Issue: 2940 | Pages: 535-535

10.1126/science.113.2940.535.a Get It

Outcomes of epilepsy surgery in the older population: not too old, not too late
Kerezoudis, Panagiotis , Parisi, Veronica , Miller, Kai J. , Marsh, W. Richard , Singh, Rohin , Worrell, Gregory A. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurosurgery | October 22, 2021 | Volume: 136 | Issue: 6 | Pages: 1607-1616

10.3171/2021.5.jns204211 | PMID 34624847 Get It

OBJECTIVE The prevalence of epilepsy in the older adult population is increasing. While surgical intervention in younger patients is supported by level I evidence, the safety and efficacy of epilepsy surgery in older individuals is less well established. The aim of this study was to evaluate seizure freedom rates and surgical outcomes in older epilepsy patients. METHODS The authors’ institutional electronic database was queried for patients older than 50 who had undergone epilepsy surgery during 2002–2018. Cases were grouped into 50–59, 60–69, and 70+ years old. Seizure freedom at the last follow-up constituted the primary outcome of interest. The institutional analysis was supplemented by a literature review and meta-analysis (random effects model) of all published studies on this topic as well as by an analysis of complication rates, mortality rates, and cost data from a nationwide administrative database (Vizient Inc., years 2016–2019). RESULTS A total of 73 patients (n = 16 for 50–59 years, n = 47 for 60–69, and n = 10 for 70+) were treated at the authors’ institution. The median age was 63 years, and 66% of the patients were female. At a median follow-up of 24 months, seizure freedom was 73% for the overall cohort, 63% for the 50–59 group, 77% for the 60–69 group, and 70% for the 70+ group. The literature search identified 15 additional retrospective studies (474 cases). Temporal lobectomy was the most commonly performed procedure (73%), and mesial temporal sclerosis was the most common pathology (52%), followed by nonspecific gliosis (19%). The pooled mean follow-up was 39 months (range 6–114.8 months) with a pooled seizure freedom rate of 65% (95% CI 59%–72%). On multivariable meta-regression analysis, an older mean age at surgery (coefficient [coeff] 2.1, 95% CI 1.1–3.1, p < 0.001) and the presence of mesial temporal sclerosis (coeff 0.3, 95% CI 0.1–0.6, p = 0.015) were the most important predictors of seizure freedom. Finally, analysis of the Vizient database revealed mortality rates of 0.5%, 1.1%, and 9.6%; complication rates of 7.1%, 10.1%, and 17.3%; and mean hospital costs of $31,977, $34,586, and $40,153 for patients aged 50–59, 60–69, and 70+ years, respectively. CONCLUSIONS While seizure-free outcomes of epilepsy surgery are excellent, there is an expected increase in morbidity and mortality with increasing age. Findings in this study on the safety and efficacy of epilepsy surgery in the older population may serve as a useful guide during preoperative decision-making and patient counseling.
Contamination of Distilled Water
Thomas, Paul J.

Mayo Clinic

Science | October 22, 2021 | Volume: 175 | Issue: 4017 | Pages: 8-10

10.1126/science.175.4017.8.c Get It

Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe
Libby, Peter , Mallat, Ziad , Weyand, Cornelia M. , Weyand, Cornelia , Libby, Peter

Mayo Clinic

Cardiovascular Research | October 22, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/cvr/cvab332 | PMID 34698765 Get It

The Calorimetric Method of Determining Blood Flow in the Extremities
Sheard, Charles

Mayo Clinic

Science | October 22, 2021 | Volume: 64 | Issue: 1661 | Pages: 427-428

10.1126/science.64.1661.427.c Get It

Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids May Extend above and below Pons and Is Associated with Other Autoimmune Diseases
Berry, Brent , Joppa, Stephanie, Labin, Edward, Puram, Vikram , McCleary, Kaci , Clark, H. Brent , Nelson, Flavia , Clark, H Brent

Mayo Clinic

Life | October 22, 2021 | Volume: 11 | Issue: 11 | Pages: 1120

10.3390/life11111120 | PMID 34832996 Get It

Many autoimmune diseases can affect the central nervous system, and their varying clinical presentations often confound a straightforward diagnosis. In this report, we describe a unique presentation of CLIPPERS syndrome. To our knowledge, this is the first case to demonstrate significant supratentorial involvement with symmetric and non-confluent lesions in the medial orbitofrontal cortex; additionally, this is the second case to describe an association between diagnoses of hypothyroidism and CLIPPERS.
Mass Customized Outlook for Regenerative Heart Failure Care
Yamada, Satsuki , Bartúnek, Jozef , Behfar, Atta , Terzic, André

Mayo Clinic

International Journal of Molecular Sciences | October 22, 2021 | Volume: 22 | Issue: 21 | Pages: 11394

10.3390/ijms222111394 | PMID 34768825 Get It

Heart failure pathobiology is permissive to reparative intent. Regenerative therapies exemplify an emerging disruptive innovation aimed at achieving structural and functional organ restitution. However, mixed outcomes, complexity in use, and unsustainable cost have curtailed broader adoption, mandating the development of novel cardio-regenerative approaches. Lineage guidance offers a standardized path to customize stem cell fitness for therapy. A case in point is the molecular induction of the cardiopoiesis program in adult stem cells to yield cardiopoietic cell derivatives designed for heart failure treatment. Tested in early and advanced clinical trials in patients with ischemic heart failure, clinical grade cardiopoietic cells were safe and revealed therapeutic improvement within a window of treatment intensity and pre-treatment disease severity. With the prospect of mass customization, cardiopoietic guidance has been streamlined from the demanding, recombinant protein cocktail-based to a protein-free, messenger RNA-based single gene protocol to engineer affordable cardiac repair competent cells. Clinical trial biobanked stem cells enabled a systems biology deconvolution of the cardiopoietic cell secretome linked to therapeutic benefit, exposing a paracrine mode of action. Collectively, this new knowledge informs next generation regenerative therapeutics manufactured as engineered cellular or secretome mimicking cell-free platforms. Launching biotherapeutics tailored for optimal outcome and offered at mass production cost would contribute to advancing equitable regenerative care that addresses population health needs.
Genotype-Phenotype Correlations in PMM2-CDG
Vaes, Laurien, Rymen, Daisy , Cassiman, David , Ligezka, Anna N. , Vanhoutvin, Nele, Quelhas, Dulce , Witters, Peter , Ligęzka, Anna , Witters, Peter , Morava, Éva

Mayo Clinic

Genes | October 22, 2021 | Volume: 12 | Issue: 11 | Pages: 1658

10.3390/genes12111658 | PMID 34828263 Get It

PMM2-CDG is a rare disease, causing hypoglycosylation of multiple proteins, hence preventing full functionality. So far, no direct genotype–phenotype correlations have been identified. We carried out a retrospective cohort study on 26 PMM2-CDG patients. We collected the identified genotype, as well as continuous variables indicating the disease severity (based on Nijmegen Pediatric CDG Rating Score or NPCRS) and dichotomous variables reflecting the patients’ phenotype. The phenotypic effects of patients’ genotype were studied using non-parametric and Chi-Square tests. Seventeen different pathogenic variants have been studied. Variants with zero enzyme activity had no significant impact on the Nijmegen score. Pathogenic variants involving the stabilization/folding domain have a significantly lower total NPCRS (p = 0.017): presence of the p.Cys241Ser mutation had a significantly lower subscore 1,3 and NPCRS (p = 0.04) and thus result in a less severe phenotype. On the other hand, variants involving the dimerization domain, p.Pro113Leu and p.Phe119Leu, resulted in a significantly higher NPCRS score (p = 0.002), which indicates a worse clinical course. These concepts give a better insight in the phenotypic prognosis of PMM2-CDG, according to their molecular base.
Word Fluency Test Performance in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech
Scheffel, Lucia , Josephs, Keith A. , Strand, Edythe A. , Josephs, Keith A , Duffy, Joseph R.

Mayo Clinic

American Journal of Speech-Language Pathology | October 22, 2021 | Volume: 30 | Issue: 6 | Pages: 2635-2642

10.1044/2021_ajslp-21-00058 | PMID 34674540 Get It

Purpose This study compared performance on three-word fluency measures among individuals with primary progressive aphasia (PPA) and primary progressive apraxia of speech (PPAOS), and examined the relationship between word fluency and other measures of language and speech. Method This study included 106 adults with PPA and 30 adults with PPAOS. PPA participants were divided into three clinical subgroups: semantic (svPPA), logopenic (lvPPA), and nonfluent/agrammatic with or without apraxia of speech (nfPPA). Category fluency, letter fluency, and action/verb fluency tasks were administered to all participants. Results The four clinical groups performed abnormally on the word fluency measures, although not to a degree that represented high sensitivity to their PPA or PPAOS diagnosis. All PPA subgroups produced fewer words compared to individuals with PPAOS on all word fluency measures. Moderate correlations were found between word fluency and aphasia severity and naming performance in some of the clinical groups. Conclusions Word fluency measures are often challenging for individuals with PPA and PPAOS, but they are not of equal difficulty, with letter fluency being the most difficult. Differences among word fluency tests also vary to some degree as a function of the clinical group in question, with least impairment in PPAOS. However, the findings of this study do not support statistically significant differences in word fluency task performance among the PPA subgroups. Correlations suggest that word fluency performance in PPA is at least partly related to aphasia severity.
Identification of cbiO Gene Critical for Biofilm Formation by MRSA CFSa36 Strain Isolated from Pediatric Patient with Cystic Fibrosis
Liu, Ying , Yang, Junshu, Ji, Michelle M., Phillips, James , Wylam, Mark E. , Ji, Yinduo , Wylam, Mark, Phillips, James

Mayo Clinic

Pathogens | October 21, 2021 | Volume: 10 | Issue: 11 | Pages: 1363

10.3390/pathogens10111363 | PMID 34832519 Get It

The colonization of Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA), has a detrimental effect on the respiratory care of pediatric patients with cystic fibrosis (CF). In addition to being resistant to multiple antibiotics, S. aureus also has the ability to form biofilms, which makes the infection more difficult to treat and eradicate. In this study, we examined the ability of S. aureus strains isolated from pediatric patients with CF to form biofilms. We screened a transposon mutant library of MRSA and identified a putative cobalt transporter ATP binding domain (cbiO) that is required for biofilm formation. We discovered that deleting cbiO creating a cbiO null mutant in CFSa36 (an MRSA strain isolated from a patient with cystic fibrosis) significantly hinders the ability of CFSa36 to form biofilm. The complementation of cbiO restored the ability of the cbiO deletion mutant to generate biofilm. Interestingly, we revealed that incorporating extra copper ions to the chemically defined medium (CDM) complemented the function of cbiO for biofilm formation in a dose-dependent manner, while the addition of extra iron ions in CDM enhanced the effect of cbiO null mutation on biofilm formation. In addition, neither the addition of certain extra amounts of copper ions nor iron ions in CDM had an impact on bacterial growth. Taken together, our findings suggest that cbiO mediates biofilm formation by affecting the transportation of copper ions in the MRSA CFSa36 strain. This study provides new insights into the molecular basis of biofilm formation by S. aureus.